Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: Jack Hartmann who wrote (551)	10/4/2001 12:31:58 PM
From: Jack Hartmann	Respond to of 687

GS on MDT 10/4/01 Medtronic, Inc., Abbott Laboratories EPS (FY Apr): 2002E US$1.22, 2003E US$1.43 Recommended List Medtronic, Inc. MDT, $44.40 EPS (FY Dec): 2001E US$1.88, 2002E US$2.27 Recommended List Abbott Laboratories ABT, $51.45 We continue to recommend purchase of Abbott, Baxter, Medtronic, and Stryker shares. We also find St. Jude shares attractive with a trading buy rating. We expect quarterly results to generally meet our expectations, as manufacturers of life-saving technologies remain relatively immune to the economic downturn. In our opinion, there is little impact to the medical device industry from the unfortunate events of September 11, since the majority of products are delivered via ground transport. The weakening dollar should also benefit device companies since significant international exposure is the norm. We believe that long-term fundamentals remain intact and maintain our positive outlook. Jack